Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

30 trials with published results (36%)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

4.8%

4 terminated out of 83 trials

Success Rate

92.6%

+6.1% vs benchmark

Late-Stage Pipeline

27%

22 trials in Phase 3/4

Results Transparency

60%

30 of 50 completed with results

Key Signals

30 with results93% success

Data Visualizations

Phase Distribution

74Total
Not Applicable (38)
Early P 1 (1)
P 1 (1)
P 2 (12)
P 3 (14)
P 4 (8)

Trial Status

Completed50
Unknown14
Withdrawn9
Terminated4
Recruiting2
Not Yet Recruiting2

Trial Success Rate

92.6%

Benchmark: 86.5%

Based on 50 completed trials

Clinical Trials (83)

Showing 20 of 20 trials
NCT07542444Not ApplicableCompleted

Craniosacral Osteopathic Treatment for Chronic Sinusitis

NCT05295459Phase 3CompletedPrimary

Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults (ENLIGHTEN 2)

NCT00880516Active Not RecruitingPrimary

Genetic Factors in Chronic Sinusitis

NCT04362501Phase 2CompletedPrimary

Efficacy of Dupilumab for Patients With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)

NCT06824649Phase 4Not Yet RecruitingPrimary

Biologics in Chronic Rhinosinusitis With Nasal Polyposis

NCT06398899Not ApplicableCompleted

Sugammadex v.s. Neostigmine/Glycopyrrolate

NCT04852562Not ApplicableCompletedPrimary

The Effect of Modified Radical Endoscopic Sinus Surgery on Eosinopilic Chronic Rhinosinusitus With Nasal Polyps

NCT07151313Not ApplicableNot Yet RecruitingPrimary

Efficacy of Bee Venom Phonophoresis in Treating Chronic Sinusitis:

NCT05983003CompletedPrimary

Research on Identifying and Treatment Prognosis of Chronic Rhinosinusitis Based on Image and Sequencing Data

NCT07073664Not ApplicableEnrolling By InvitationPrimary

A Study Evaluating the Efficacy of Endoscope Ethmoid Infundibulum Expansion Surgery (EEIES) Combined With Stapokibart in the Treatment of Type 2 Chronic Rhinosinusitis

NCT05219968Phase 3CompletedPrimary

Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults

NCT06036927Phase 2CompletedPrimary

A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal Polyps

NCT04678856Phase 3Completed

Dupilumab in CRSsNP

NCT06773494CompletedPrimary

Clinical and Radiographic Evidence of Alleviation of Preoperative Chronic Sinusitis After Open Sinus Allogeneic Bone Augmentation Surgery: A Retrospective Observational Study

NCT05035654Phase 2CompletedPrimary

LYR-220 for Adult Subjects With Chronic Rhinosinusitis (BEACON Study)

NCT00231062Phase 3CompletedPrimary

Clinical Evaluation to Confirm Safety and Efficacy of Sinuplasty in the Paranasal Sinuses (CLEAR)

NCT00939471Not ApplicableCompletedPrimary

Safety and Efficacy of Balloon Sinuplasty in Pediatric Sinusitis

NCT00939393Not ApplicableCompletedPrimary

Balloon Sinus Dilation In Office or OR

NCT06272123RecruitingPrimary

Endotypic Stability in CRS

NCT06198894Not ApplicableRecruitingPrimary

Steroid-eluting Sinus Stent for Chronic Rhinosinusitis Patients With Uncontrolled Postoperative Symptoms

Scroll to load more

Research Network

Activity Timeline